Soon after, the company launched an AI medical imaging platform capable of diagnosing a broad list of illnesses, and a cloud-based ecosystem for sharing and collaboration between domestic healthcare AI companies.

The same year, an intelligent robot developed by iFlyTek passed China’s written national qualification exam for doctors, in what was hailed as a game changer for the country’s strained healthcare system.

These developments are among a range of AI applications in healthcare which have helped the country’s response to the coronavirus outbreak.